M. Foster

Hras1‐selected, chromosome‐mediated transformants vary in phenotype in vitro and tumorigenic potential in vivo

D. Porteous, C. M. Steel, G. Cranston, 1986, International journal of cancer.

Tumorigenicity of human lymphoblastoid cell lines, acquired during in vitro culture and associated with chromosome gains

C. M. Steel, J. Hay, A. Busuttil, 1984, International journal of cancer.

Relationship between OKT3 administration, EBV seroconversion, and the lymphoproliferative syndrome in pediatric liver transplant recipients.

W. Andrews, T. Renard, M. Foster, 1991, Transplantation proceedings.

Gene expression in oestrogen-dependent human breast cancer xenograft tumours.

H. J. Evans, D. Carter, C. Steel, 1990, British Journal of Cancer.

Suppression of malignancy in human lymphoid cell hybrids: the role of differentiation.

C. M. Steel, J. Gordon, J. Ross, 1989, Journal of cell science.

The gross pathology and histological features of tumours produced by inoculation of human cell lines into immune‐deprived mice

C. M. Steel, A. Busuttil, M. Foster, 1986, The Journal of pathology.

Angiogenic and immune parameters during recombinant interferon-alpha2b adjuvant treatment in patients with melanoma.

D. Dréau, R. White, W. Holder, 2001, Oncology research.